Karrels James

Avg. Two Year Performance

No purchase track record
17% Avg. Sale Return
8% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return5%6%7%8%17%
Sale Success Rate1 of 21 of 21 of 21 of 21 of 2
Drugs » Biotechnology

SVP, CFO and Secretary:

Holdings: 143.46K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--